
### [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759)
**Label:** b-cell non-Hodgkin lymphoma

**Subclasses:** [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0017599](http://purl.obolibrary.org/obo/MONDO_0017599) (splenic diffuse red pulp small b-cell lymphoma), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0017596](http://purl.obolibrary.org/obo/MONDO_0017596) (diffuse large b-cell lymphoma of the central nervous system), [MONDO:0014241](http://purl.obolibrary.org/obo/MONDO_0014241) (leukemia, acute lymphoblastic, susceptibility to, 3), [MONDO:0018621](http://purl.obolibrary.org/obo/MONDO_0018621) (lymphoplasmacytic lymphoma without IgM production), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive b-cell non-Hodgkin lymphoma), [MONDO:0018225](http://purl.obolibrary.org/obo/MONDO_0018225) (ALK-positive large b-cell lymphoma), [MONDO:0017597](http://purl.obolibrary.org/obo/MONDO_0017597) (T-cell/histiocyte rich large b cell lymphoma), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent b-cell non-Hodgkin lymphoma), [MONDO:0020323](http://purl.obolibrary.org/obo/MONDO_0020323) (primary mediastinal large b-cell lymphoma), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0020324](http://purl.obolibrary.org/obo/MONDO_0020324) (intravascular large b-cell lymphoma), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0015814](http://purl.obolibrary.org/obo/MONDO_0015814) (primary cutaneous follicle center lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0015813](http://purl.obolibrary.org/obo/MONDO_0015813) (primary cutaneous marginal zone b-cell lymphoma), [MONDO:0017347](http://purl.obolibrary.org/obo/MONDO_0017347) (Plasmablastic lymphoma), [MONDO:0017600](http://purl.obolibrary.org/obo/MONDO_0017600) (hairy cell leukemia variant), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0018876](http://purl.obolibrary.org/obo/MONDO_0018876) (mantle cell lymphoma), [MONDO:0019465](http://purl.obolibrary.org/obo/MONDO_0019465) (Nodal marginal zone b-cell lymphoma), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0013088](http://purl.obolibrary.org/obo/MONDO_0013088) (FL1), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0019461](http://purl.obolibrary.org/obo/MONDO_0019461) (b-cell prolymphocytic leukemia), [MONDO:0019462](http://purl.obolibrary.org/obo/MONDO_0019462) (splenic marginal zone lymphoma), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0007897](http://purl.obolibrary.org/obo/MONDO_0007897) (leukemia, chronic lymphocytic), [MONDO:0012936](http://purl.obolibrary.org/obo/MONDO_0012936) (leukemia, chronic lymphocytic, susceptibility to, 5), [MONDO:0007650](http://purl.obolibrary.org/obo/MONDO_0007650) (malt lymphoma), [MONDO:0006383](http://purl.obolibrary.org/obo/MONDO_0006383) (primary cutaneous diffuse large b-cell lymphoma, leg type), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0012935](http://purl.obolibrary.org/obo/MONDO_0012935) (leukemia, chronic lymphocytic, susceptibility to, 4), [MONDO:0012318](http://purl.obolibrary.org/obo/MONDO_0012318) (leukemia, chronic lymphocytic, susceptibility to, 1), [MONDO:0012934](http://purl.obolibrary.org/obo/MONDO_0012934) (leukemia, chronic lymphocytic, susceptibility to, 3), [MONDO:0018813](http://purl.obolibrary.org/obo/MONDO_0018813) (high grade b-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement), [MONDO:0018935](http://purl.obolibrary.org/obo/MONDO_0018935) (hairy cell leukemia), 

**Corr. equiv. classes:** [Orphanet:300869](http://www.orpha.net/ORDO/Orphanet_300869), [Orphanet:300849](http://www.orpha.net/ORDO/Orphanet_300849), [Orphanet:300888](http://www.orpha.net/ORDO/Orphanet_300888), [Orphanet:300846](http://www.orpha.net/ORDO/Orphanet_300846), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:86854](http://www.orpha.net/ORDO/Orphanet_86854), [Orphanet:48686](http://www.orpha.net/ORDO/Orphanet_48686), [Orphanet:178540](http://www.orpha.net/ORDO/Orphanet_178540), [Orphanet:289666](http://www.orpha.net/ORDO/Orphanet_289666), [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842), [Orphanet:86872](http://www.orpha.net/ORDO/Orphanet_86872), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [Orphanet:178544](http://www.orpha.net/ORDO/Orphanet_178544), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [Orphanet:86852](http://www.orpha.net/ORDO/Orphanet_86852), [Orphanet:289661](http://www.orpha.net/ORDO/Orphanet_289661), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [OMIM:610430](http://purl.obolibrary.org/obo/OMIM_610430), [OMIM:615545](http://purl.obolibrary.org/obo/OMIM_615545), [Orphanet:98838](http://www.orpha.net/ORDO/Orphanet_98838), [Orphanet:98839](http://www.orpha.net/ORDO/Orphanet_98839), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:58017](http://www.orpha.net/ORDO/Orphanet_58017), [Orphanet:178536](http://www.orpha.net/ORDO/Orphanet_178536), [OMIM:137245](http://purl.obolibrary.org/obo/OMIM_137245), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:86869](http://www.orpha.net/ORDO/Orphanet_86869), [Orphanet:300857](http://www.orpha.net/ORDO/Orphanet_300857), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:364043](http://www.orpha.net/ORDO/Orphanet_364043), [Orphanet:300878](http://www.orpha.net/ORDO/Orphanet_300878), [Orphanet:52417](http://www.orpha.net/ORDO/Orphanet_52417), [Orphanet:52416](http://www.orpha.net/ORDO/Orphanet_52416), [Orphanet:86867](http://www.orpha.net/ORDO/Orphanet_86867), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:480541](http://www.orpha.net/ORDO/Orphanet_480541), [Orphanet:443159](http://www.orpha.net/ORDO/Orphanet_443159), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 22.40%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 22.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 18.69%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 18.64%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 18.64%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 18.64%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 18.63%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 18.63%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 18.63%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 18.63%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 18.35%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 17.30%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 14.53%
- Thing 14.52%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 14.52%


